Learning disability
is a neurological disorder that usually cause due to genetic factors. This disorder alters
brain functioning in a manner that affects the
response power and perception of information in humans. Learning basic skills such as reading,
writing can be difficult for
such patients. This disorder can also impede higher level skills such as time
planning, management, abstract reasoning, long term or short term memory and
attention. It can hamper an individual’s relationships
with family, friends and in the workplace. Few of the learning disabilities are dyslexia,
dyscalculia, dyspraxia, dysgraphia, auditory, and visual processing disorders,
and attention deficit hyperactivity disorder (ADHD).
According to a report published by Allied Market Research,
the global
learning disabilities treatment market
size is projected to grow with a considerable CAGR from 2019 to 2027.
Government initiatives across several nations is promoting awareness and
treatment for mentally disabled children. With this drift on board, the key
market players are currently focusing
on the development of learning software and applications in compliance with
occupational therapy, which in turn, is providing lucrative opportunities for
the growth of the market.
Request for Sample Report for
More Insights @ https://www.alliedmarketresearch.com/request-sample/7874
Top Leading Players:
·
Pfizer, Inc.
·
Forest
Laboratories, Inc.
·
Eli Lilly
and Company
·
Novartis
AG and Shire Plc.
·
Therapro,
Inc.
·
Tumble N’
Dots, Inc.
·
Texthelp
Ltd.
·
CogniFit
·
IMSE
Covid-19 scenario-
However, during the outbreak of
the COVID-19 pandemic, the demand for implant surgeries decreased significantly, which had a negative impact
on the growth of the global learning disabilities treatment market. In order to
maintain the social distancing norms, patients with moderate and severe
disabilities avoided hospital visits. The supply chain around the world was
disrupted, due to which, the market players had reduced the investments in raw
materials and resources that are needed to undergo the implant surgeries.
Though there is no
proper cure available for learning disabilities, early diagnosis with proper medication can help a bit in
lowering the intensity of the disorder, thereby can enhance the quality of life of the
patient to some extent. If learning
disabilities are not treated, a child may start to feel frustrated, which can result
to low self-esteem and other problems.
Medications for the learning
disability treatment are of two types i.e. stimulant and non –stimulant. Psychoactive drugs such as Focalin, Ritalin, Vynase, and
Dexedrin are prescribed to improve the functioning of central nervous system. Non-stimulants
are prescribed to treat anxiety & depression mostly encountered in patients
suffering with ADHD.
Moreover, assistive technology is gathering immense popularity,
as it is able to offer occupational therapy and cognitive behavioral therapy in
the form of learning applications. This technology helps children suffering
from dyslexia and dyspraxia who face difficulty in word recognition, reading
and writing fluency etc.
0 Comments